scholarly journals Anti-Mullerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment

2013 ◽  
Vol 28 (7) ◽  
pp. 1899-1907 ◽  
Author(s):  
J. A. Visser ◽  
A. C. S. Hokken-Koelega ◽  
G. R. J. Zandwijken ◽  
A. Limacher ◽  
M. B. Ranke ◽  
...  
1995 ◽  
Vol 43 (4) ◽  
pp. 141-143 ◽  
Author(s):  
K. Takano ◽  
K. Shizume ◽  
I. Hibi ◽  
M. Ogawa ◽  
Y. Okada ◽  
...  

2020 ◽  
Vol 17 (1) ◽  
pp. 47-50
Author(s):  
Su Hyun Yoo ◽  
Moon Bae Ahn ◽  
Shin Hee Kim ◽  
Won Kyoung Cho ◽  
Min Ho Jung ◽  
...  

2012 ◽  
Vol 21 (2) ◽  
pp. 29-34 ◽  
Author(s):  
Hitoshi Kohno ◽  
Yutaka Igarashi ◽  
Keiichi Ozono ◽  
Kenji Ohyama ◽  
Masamichi Ogawa ◽  
...  

2008 ◽  
Vol 55 (6) ◽  
pp. 1065-1070 ◽  
Author(s):  
Tsuyoshi ISOJIMA ◽  
Susumu YOKOYA ◽  
Junko ITO ◽  
Reiko HORIKAWA ◽  
Toshiaki TANAKA

2007 ◽  
Vol 150 (6) ◽  
pp. 587-591 ◽  
Author(s):  
Lea Ann Matura ◽  
Vandana Sachdev ◽  
Vladimir K. Bakalov ◽  
Douglas R. Rosing ◽  
Carolyn A. Bondy

Author(s):  
Isabel Periquito ◽  
Catarina Carrusca ◽  
Joana Morgado ◽  
Brígida Robalo ◽  
Carla Pereira ◽  
...  

AbstractTurner syndrome is a common genetic disorder with an incidence of 1 in 2500 live births. Spontaneous fertility is rare in such patients and is most likely in women with mosaicism or very distal Xp deletions. The authors report an unusual case of familial Turner syndrome in a woman with mosaicism 45,X/46,Xdel(Xp) karyotype with three documented spontaneous pregnancies, which resulted in two daughters with 46,Xdel(X)(p11.4)mat karyotype and a healthy son. The mother was first diagnosed by the age of 11 and did not receive contraceptive medication, due to information that she would be infertile. Both daughters were referred to an endocrinology unit and are now under growth hormone treatment, and have been growing in the 3rd percentile. This family illustrates the complexity and difficulties in counseling, follow-up and treatment in Turner syndrome, namely referring to a tertiary center, fertility and treatment such as growth hormone and hormonal replacement, due to the heterogeneity of the clinical spectrum.


Sign in / Sign up

Export Citation Format

Share Document